Arie Stoppelenburg

Dr. Arie Stoppelenburg

Department of Rheumatology, University Medical Centre Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASArie Stoppelenburg
Arie Stoppelenburg
VSVahid Salimi
Vahid Salimi
MHMarije Hennus
Marije Hennus
MPMaud Plantinga
Maud Plantinga
RVRon Huis In ’t Veld
Ron Huis In ’t Veld
MBMarianne Boes
Marianne Boes
Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characterized by excessive neutrophil infiltration which contributes to RSV induced pathology. The cytokine IL-17A enhances neutrophil infiltration into virus infected lungs. IL-17A is however best known as an effector of adaptive immune responses. The role of IL-17A in early immune modulation in RSV infection is unknown. We aimed to elucidate whether local IL-17A facilitates the innate neutrophil infiltration into RSV infected lungs prior to adaptive immunity. To this end, we studied IL-17A production in newborns that were hospitalized for severe RSV bronchiolitis. In tracheal aspirates we measured IL-17A concentration and neutrophil counts. We utilized cultured human epithelial cells to test if IL-17A regulates RSV infection-induced IL-8 release as mediator of neutrophil recruitment. In mice we investigated the cell types that are responsible for early innate IL-17A production during RSV infection. Using IL-17A neutralizing antibodies we tested if IL-17A is responsible for innate neutrophil infiltration in mice. Our data show that increased IL-17A production in newborn RSV patient lungs correlates with subsequent neutrophil counts recruited to the lungs. IL-17A potentiates RSV-induced production of the neutrophil-attracting chemokine IL-8 by airway epithelial cells in vitro. Various lung-resident lymphocytes produced IL-17A during early RSV infection in Balb/c mice, of which a local population of CD4 T cells stood out as the predominant RSV-induced cell type. By removing IL-17A during early RSV infection in mice we showed that IL-17A is responsible for enhanced innate neutrophil infiltration in vivo. Using patient material, in vitro studies, and an animal model of RSV infection, we thus show that early local IL-17A production in the airways during RSV bronchiolitis facilitates neutrophil recruitment with pathologic consequences to infant lungs.

1 May 2014 in The American Journal of Pathology
Verified
Journal Article
Closed access
ASArie Stoppelenburg
Arie Stoppelenburg
SRSytze de Roock
Sytze de Roock
MHMarije P. Hennus
Marije P. Hennus
LBLouis Bont
Louis Bont
MBMarianne Boes
Marianne Boes

1 May 2018 in Clinical Immunology
Verified
Journal Article
Open access
DVDorit Verhoeven
Dorit Verhoeven
ASArie Stoppelenburg
Arie Stoppelenburg
FMFriederike Meyer-Wentrup
Friederike Meyer-Wentrup
MBMarianne Boes
Marianne Boes
Primary immunodeficiency disorders (PIDs) convey increased susceptibility to infections and sometimes to malignancies, particularly lymphomas. Such cancer development can be contributed by immune impairments resulting in weakened immunological surveillance against (pre)malignant cells and oncogenic viruses. Molecular defects in PID-patients are therefore being clarified, identifying new targets for innovative immunotherapy. Particularly pediatric cancers are being scrutinized, where over one-third of cancer-related deaths are accounted for by leukemia and lymphomas. Here we review how immunopathogenic mechanisms of several PIDs might associate with lymphoma development. We furthermore delineate existing immunotherapy strategies in adults for potential therapeutic application in childhood leukemia and lymphomas.

19 September 2013 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
ASArie Stoppelenburg
Arie Stoppelenburg
JHJohannes Hendrick von Hegedus
Johannes Hendrick von Hegedus
RVRon Huis In'T Veld
Ron Huis In'T Veld
LBLouis Bont
Louis Bont
MBMarianne Boes
Marianne Boes

1 September 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SRSytze De Roock
Sytze De Roock
ASArie Stoppelenburg
Arie Stoppelenburg
RSRianne Scholman
Rianne Scholman
SHSanne B.E.A. Hoeks
Sanne B.E.A. Hoeks
JMJenny Meerding
Jenny Meerding
MBMarianne Boes
Marianne Boes

23 October 2012 in Viruses
Verified
Journal Article
Open access
PDF file
DHDanielle Horst
Danielle Horst
RGRuben Geerdink
Ruben Geerdink
AGAnna M. Gram
Anna M. Gram
ASArie Stoppelenburg
Arie Stoppelenburg
MRMaaike E. Ressing
Maaike E. Ressing
The immune system plays a major role in protecting the host against viral infection. Rapid initial protection is conveyed by innate immune cells, while adaptive immunity (including T lymphocytes) requires several days to develop, yet provides high specificity and long-lasting memory. Invariant natural killer T (iNKT) cells are an unusual subset of T lymphocytes, expressing a semi-invariant T cell receptor together with markers of the innate NK cell lineage. Activated iNKT cells can exert direct cytolysis and can rapidly release a variety of immune-polarizing cytokines, thereby regulating the ensuing adaptive immune response. iNKT cells recognize lipids in the context of the antigen-presenting molecule CD1d. Intriguingly, CD1d-restricted iNKT cells appear to play a critical role in anti-viral defense: increased susceptibility to disseminated viral infections is observed both in patients with iNKT cell deficiency as well as in CD1d- and iNKT cell-deficient mice. Moreover, viruses have recently been found to use sophisticated strategies to withstand iNKT cell-mediated elimination. This review focuses on CD1d-restricted lipid presentation and the strategies viruses deploy to subvert this pathway.